D-dimer Testing Market Segments, Growth, Size, Share, Key Players and Forecast 2024-2032

Written by Mark Smith  »  Updated on: August 05th, 2024

The latest report by IMARC Group, titled “D-dimer Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” offers a comprehensive analysis of the D-dimer testing market analysis. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global D-dimer testing market size reached US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3.4% during 2024-2032.

D-dimer Testing Market Trends:

The global D-dimer testing market is expanding due to increasing awareness of clotting disorders, advancements in diagnostic technologies, and a growing emphasis on early disease detection. D-dimer tests are used to measure the presence of a specific protein fragment in the blood that indicates the formation and breakdown of blood clots. These tests are critical for diagnosing conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC).

A significant driver of the D-dimer testing market is the rising prevalence of clotting disorders and conditions that require timely diagnosis. The incidence of diseases like DVT and PE is increasing globally due to factors such as an aging population, sedentary lifestyles, and obesity. The demand for accurate and rapid diagnostic tools to manage these conditions effectively is boosting the market for D-dimer tests.

Get a Sample Copy of this Report: https://www.imarcgroup.com/d-dimer-testing-market/requestsample

D-dimer Testing Market Scope and Growth Analysis:

From a market scope and analysis perspective, the global D-dimer testing market includes various segments such as test types (immunoassays, rapid tests), end-users (hospitals, diagnostic laboratories, clinics), and regions. Each segment addresses different needs within the diagnostic landscape, offering a range of solutions for different healthcare settings. The market features a mix of key players including diagnostic device manufacturers, biotechnology companies, and healthcare providers.

Geographically, North America, Europe, and Asia-Pacific are significant markets for D-dimer testing, with North America and Europe leading in terms of technology adoption and healthcare infrastructure. The presence of advanced healthcare facilities and high levels of awareness about clotting disorders in these regions support market growth. The Asia-Pacific region, with its large and diverse population, represents a growing market with increasing investments in healthcare infrastructure and diagnostic technologies.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/d-dimer-testing-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Abbott Laboratories
  • BioMedica Diagnostics
  • biomérieux SA
  • Diazyme Laboratories Inc. (General Atomics)
  • Hoffmann-La Roche Ltd.
  • HORIBA Ltd.
  • Quidel Corporation
  • Sekisui Diagnostics LLC (Sekisui Chemical Co. Ltd.)
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Unbound Medicine Inc
  • Werfen

D-dimer Testing Market Segmentation:

Our report has categorized the market based on region, test type, product, method, application, and end use.

Breakup by Test Type:

  • Clinical Laboratory Tests
  • Point-of-Care Tests

Breakup by Product:

  • Analyzers
  • Reagents and Consumables

Breakup by Method:

  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Latex-enhanced Immunoturbidimetric Assays
  • Fluorescence Immunoassays
  • Others

Breakup by Application:

  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Disseminated Intravascular Coagulation (DIC)
  • Others

Breakup by End Use:

  • Hospitals
  • Academic and Research Institutes
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2018-2023)
  • Market Outlook (2024-2032)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145


Disclaimer:

We do not claim ownership of any content, links or images featured on this post unless explicitly stated. If you believe any content infringes on your copyright, please contact us immediately for removal ([email protected]). Please note that content published under our account may be sponsored or contributed by guest authors. We assume no responsibility for the accuracy or originality of such content.


Related Posts